India lifts patents for GSK, Roche's breast cancer drugs

08/4/2013 | Daily Star (Bangladesh), The · Reuters

India struck down a patent covering GlaxoSmithKline's breast-cancer drug Tykerb over concerns that the treatment is not innovative enough to deserve its own patent. A GSK representative said the company was evaluating an appeal. Similarly, a Roche representative confirmed that India had canceled divisional patents for the company's breast cancer treatment Herceptin over improper patent submissions.

View Full Article in:

Daily Star (Bangladesh), The · Reuters

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Marlborough, MA
Test Technician
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT